November 16, 2016 06:59 AM ESTUpdated November 17, 03:49 PM
Financing
Startups

GSK vet Ja­son Gard­ner takes the helm of Ma­gen­ta, emerg­ing from stealth with a $48.5M round

John Carroll

Editor & Founder

Ja­son Gard­ner, Ma­gen­ta CEO. Jen Ran­dall Pho­tog­ra­phy.
Ja­son Gard­ner re­turned to his old stomp­ing grounds in Cam­bridge, MA back in the fall of 2014 with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

Cari­bou lays off 32% of staff, cuts lu­pus cell ther­a­py pro­gram be­fore first pa­tient

J&J re­ports dura­bil­i­ty da­ta for blad­der can­cer 'pret­zel' drug af­ter FDA fil­ing

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times